CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 51 filers reported holding CONMED CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $313,000 | +3.3% | 182,000 | 0.0% | 0.01% | +11.1% |
Q4 2021 | $303,000 | +7.8% | 182,000 | 0.0% | 0.01% | -25.0% |
Q3 2021 | $281,000 | -4.1% | 182,000 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $293,000 | -15.6% | 182,000 | -18.0% | 0.01% | -20.0% |
Q1 2021 | $347,000 | +10.2% | 222,000 | -1.3% | 0.02% | +7.1% |
Q4 2020 | $315,000 | +64.9% | 225,000 | +31.6% | 0.01% | +40.0% |
Q3 2020 | $191,000 | +6.7% | 171,000 | 0.0% | 0.01% | +11.1% |
Q2 2020 | $179,000 | +92.5% | 171,000 | +69.3% | 0.01% | +50.0% |
Q1 2020 | $93,000 | – | 101,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opti Capital Management, LP | 45,565,000 | $70,876,000 | 6.65% |
ABSOLUTE INVESTMENT ADVISERS, LLC | 4,000,000 | $6,304,000 | 2.21% |
SHENKMAN CAPITAL MANAGEMENT INC | 9,836,000 | $15,118,000 | 1.16% |
Eisler Capital (UK) Ltd. | 17,500,000 | $27,322,000 | 1.06% |
III Capital Management | 8,246,000 | $12,799,000 | 0.82% |
OSTERWEIS CAPITAL MANAGEMENT INC | 8,930,000 | $13,847,000 | 0.76% |
SSI INVESTMENT MANAGEMENT LLC | 6,683,000 | $10,327,000 | 0.62% |
MACKAY SHIELDS LLC | 38,329,000 | $59,400,000 | 0.56% |
PALISADE CAPITAL MANAGEMENT, LP | 4,998,000 | $7,762,000 | 0.17% |
Calamos Advisors LLC | 23,047,000 | $35,765,000 | 0.16% |